NasdaqGS - Nasdaq Real Time Price USD

Pacific Biosciences of California, Inc. (PACB)

Compare
1.2400
-0.0300
(-2.37%)
As of 10:00:18 AM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
154,014
154,014
200,521
128,304
130,513
Cost of Revenue
116,732
116,732
147,741
79,269
71,653
Gross Profit
37,282
37,282
52,780
49,035
58,860
Operating Expense
327,945
327,945
363,145
353,854
237,023
Operating Income
-290,663
-290,663
-310,365
-304,819
-178,163
Net Non Operating Interest Income Expense
-13,412
-13,412
-14,343
-14,690
-12,530
Other Income Expense
-5,460
-5,460
6,549
5,261
-84,179
Pretax Income
-309,535
-309,535
-318,159
-314,248
-274,872
Tax Provision
316
316
-11,424
--
-93,649
Net Income Common Stockholders
-309,851
-309,851
-306,735
-314,248
-181,223
Diluted NI Available to Com Stockholders
-309,851
-309,851
-306,735
-314,248
-181,223
Basic EPS
-1.46
-1.13
-1.21
-1.40
-0.89
Diluted EPS
-1.46
-1.59
-1.21
-1.40
-0.89
Basic Average Shares
270,540.7500
274,488
253,629
224,550
204,136
Diluted Average Shares
270,540.7500
288,366
253,629
224,550
204,136
Total Operating Income as Reported
-474,313
-474,313
-334,467
-307,196
-210,435
Total Expenses
444,677
444,677
510,886
433,123
308,676
Net Income from Continuing & Discontinued Operation
-309,851
-309,851
-306,735
-314,248
-181,223
Normalized Income
-286,749.0300
-286,749.0300
-281,538.4183
-311,871
-125,603.4800
Interest Expense
13,412
13,412
14,343
14,690
12,530
Net Interest Income
-13,412
-13,412
-14,343
-14,690
-12,530
EBIT
-296,123
-296,123
-303,816
-299,558
-262,342
EBITDA
-242,772
-242,772
-277,282
-282,240
-250,757
Reconciled Cost of Revenue
81,387
81,387
127,364
61,951
60,068
Reconciled Depreciation
53,351
53,351
26,534
17,318
11,585
Net Income from Continuing Operation Net Minority Interest
-309,851
-309,851
-306,735
-314,248
-181,223
Total Unusual Items Excluding Goodwill
-29,243
-29,243
-26,135
-2,377
-84,272
Total Unusual Items
-29,243
-29,243
-26,135
-2,377
-84,272
Normalized EBITDA
-213,529
-213,529
-251,147
-279,863
-166,485
Tax Rate for Calcs
0.0002
0.0002
0
--
0.0003
Tax Effect of Unusual Items
-6,141.0300
-6,141.0300
-938.4183
--
-28,652.4800
12/31/2021 - 10/27/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.